English | 繁體

Search in the results

UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
Development of in silico methodology for siRNA lipid nanoparticle formulations Journal article
Gao, Haoshi, Kan, Stanislav, Ye, Zhuyifan, Feng, Yuchen, Jin, Lei, Zhang, Xudong, Deng, Jiayin, Chan, Ging, Hu, Yuanjia, Wang, Yongjun, Cao, Dongsheng, Ji, Yuanhui, Liang, Mingtao, Li, Haifeng, Ouyang, Defang. Development of in silico methodology for siRNA lipid nanoparticle formulations[J]. Chemical Engineering Journal, 2022, 442, 136310.
Authors:  Gao, Haoshi;  Kan, Stanislav;  Ye, Zhuyifan;  Feng, Yuchen;  Jin, Lei; et al.
Favorite | TC[WOS]:15 TC[Scopus]:16  IF:13.3/13.2 | Submit date：2022/05/13
Cationic Lipids  Knockdown Efficiency  Lipid Nanoparticle  Machine Learning  Molecular Dynamic Simulation  Sirna  
Acid-activatible micelleplex delivering siRNA-PD-L1 for improved cancer immunotherapy of CDK4/6 inhibition Journal article
Gao, Jing, Zhang, Hanwu, Zhou, Fengqi, Hou, Bo, Chen, Meiwan, Xie, Zhigang, Yu, Haijun. Acid-activatible micelleplex delivering siRNA-PD-L1 for improved cancer immunotherapy of CDK4/6 inhibition[J]. Chinese Chemical Letters, 2021, 32(6), 1929-1936.
Authors:  Gao, Jing;  Zhang, Hanwu;  Zhou, Fengqi;  Hou, Bo;  Chen, Meiwan; et al.
Favorite | TC[WOS]:35 TC[Scopus]:34  IF:9.4/7.3 | Submit date：2021/12/08
Acid-activatible Micelleplex  Cancer Immunotherapy  Cdk4/6 Inhibitor  Pd-l1 Knockdown  Sirna Delivery  
aP2-Cre mediated ablation of GHS-R attenuates adiposity and improves insulin sensitivity during aging Journal article
Lin L., Lee J.H., Wang R., Wang R., Sheikh-Hamad D., Zang Q.S., Sun Y.. aP2-Cre mediated ablation of GHS-R attenuates adiposity and improves insulin sensitivity during aging[J]. International Journal of Molecular Sciences, 2018, 19(10).
Authors:  Lin L.;  Lee J.H.;  Wang R.;  Wang R.;  Sheikh-Hamad D.; et al.
Favorite | TC[WOS]:9 TC[Scopus]:11 | Submit date：2019/01/15
Adipose Tissues  Ghrelin  Ghs-r  Thermogenesis  Tissue-specific Knockdown Mice  Ucp1  
DNA replication licensing protein MCM10 promotes tumor progression and is a novel prognostic biomarker and potential therapeutic target in breast cancer Journal article
Mahadevappa R., Neves H., Yuen S.M., Jameel M., Bai Y., Yuen H.-F., Zhang S.-D., Zhu Y., Lin Y., Kwok H.F.. DNA replication licensing protein MCM10 promotes tumor progression and is a novel prognostic biomarker and potential therapeutic target in breast cancer[J]. Cancers, 2018, 10(9).
Authors:  Mahadevappa R.;  Neves H.;  Yuen S.M.;  Jameel M.;  Bai Y.; et al.
Favorite | TC[WOS]:32 TC[Scopus]:32 | Submit date：2018/12/19
Breast Cancer  Knockdown  Mcm10  Overexpression  Proliferation  Survival